Integrated Biopharma INBP
OTC INBP
$0.18 +0.02 (+12.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Integrated Biopharma (INBP) Operating Expenses (2010 - 2026)

Updated

Integrated Biopharma's Operating Expenses came in at $897,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 1.9% from $880,000 a year earlier and up 10.9% from the prior quarter.

Analysis

Integrated Biopharma (INBP) Operating Expenses (2010 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Integrated Biopharma's Operating Expenses was $3.51 million, down 1.0% from FY2025.

  • Operating Expenses has declined in each of the last three fiscal years, with a five-year compound annual growth rate of -1.1% (FY2021 to FY2026).
  • Going back by fiscal year, Operating Expenses was $3.54 million in FY2025 (-2.5%), $3.63 million in FY2024 (-7.8%), $3.94 million in FY2023 (+3.5%) and $3.81 million in FY2022 (+3.0%).
  • The five-year range for quarterly Operating Expenses is $809,000 (fiscal Q3 2026) to $1.1 million (fiscal Q2 2023).
  • Year-over-year, Operating Expenses increased in 1 of the last eight quarters, with an average decline of 1.8%.
  • The fastest year-over-year change in Operating Expenses over five years came in fiscal Q1 2023 (growth of 15.3%), and the weakest in fiscal Q2 2024 (a decline of 11.9%).
  • Business Quant data shows INBP's Operating Expenses at $809,000 (Q3 2026), $943,000 (Q2 2026) and $856,000 (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Procter & Gamble 336.76 Bn 292.75 Bn 10.28 Bn 6.33 Bn
2 Colgate Palmolive 67.18 Bn 62.24 Bn 3.30 Bn 2.13 Bn
3 Estee Lauder Companies 33.32 Bn 21.40 Bn 2.74 Bn 2.78 Bn
4 Kenvue 33.09 Bn 28.70 Bn 2.30 Bn 1.60 Bn
5 Kimberly Clark 31.38 Bn 28.71 Bn 1.60 Bn -
6 Church & Dwight 22.37 Bn 20.90 Bn 693.90 Mn 252.20 Mn
7 Clorox 9.72 Bn 8.16 Bn 804.00 Mn 330.00 Mn
8 e.l.f. Beauty 6.17 Bn 5.15 Bn 398.84 Mn 280.32 Mn
9 Reynolds Consumer Products 4.71 Bn 4.37 Bn 245.00 Mn 107.00 Mn
10 Integrated Biopharma 5.59 Mn -14.75 Mn 28,000.00 897,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 897,000.00
Mar 31, 2026 809,000.00
Dec 31, 2025 943,000.00
Sep 30, 2025 856,000.00
Jun 30, 2025 880,000.00
Mar 31, 2025 812,000.00
Dec 31, 2024 969,000.00
Sep 30, 2024 881,000.00
Jun 30, 2024 882,000.00
Mar 31, 2024 893,000.00
Dec 31, 2023 972,000.00
Sep 30, 2023 886,000.00
Jun 30, 2023 907,000.00
Mar 31, 2023 964,000.00
Dec 31, 2022 1.10 Mn
Sep 30, 2022 967,000.00
Jun 30, 2022 958,000.00
Mar 31, 2022 990,000.00
Dec 31, 2021 1.02 Mn
Sep 30, 2021 839,000.00
API Access

Integrated Biopharma Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=INBP&period=max&api_key=YOUR_API_KEY